D-0402-2026 Class II Ongoing

Recalled by Chiesi USA, Inc. — Cary, NC

FDA drug recall D-0402-2026 was initiated by Chiesi USA, Inc. on Mar 17, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 7,235 vials.

Recall details

Product Type
Drugs
Report Date
Apr 1, 2026
Initiation Date
Mar 17, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,235 vials

Product description

CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within the United States

Code information

Lot #: 1213748, Exp. Date 09/2026; 1215076, 1215077, Exp. Date 10/26.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0402-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0402-2026. Report a data issue: hello@regdatalab.com.